Cited by 253Complement system in diseasesImmunodeficiency and Autoimmune DisordersCoagulation, Bradykinin, Polyphosphates, and Angioedema

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Inherited Deficiency of Mannan-Binding Lectin–Associated Serine Protease 2

Open access

Abstract

One pathway of complement activation involves mannan-binding lectin and its associated serine protease 2 (MASP-2). MASP-2 deficiency was identified in an adult with a history of ulcerative colitis, erythema multiforme bullosum, and possible systemic lupus erythematosus. He had had recurrent episodes of severe pneumococcal pneumonia. Studies documented that his mannan-binding lectin pathway of complement activation was not functional.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmoa022836

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A low-frequency missense variant in MASP2 (rs72550870, Asp120Gly, MAF = 3.0%), previously linked to MASP2 deficiency, is associated in trans with higher MASP1 levels (β = 0.17, P = 2.5 × 10 -15), reduced FCN2 levels (β = -0.22, P = 2.6 × 10 -32), higher FCN1 levels (β = 0.17, P = 1.4 × 10 -17) and lower C1QTNF9 levels (β = -0.12, P = 6.6 × 10 -14).

    “Similarly, we found a low-frequency missense variant in MASP2 (rs72550870, Asp120Gly, MAF = 3.0%), previously linked to MASP2 deficiency [47][48][49] , associated in trans with higher MASP1 levels (β = 0.17, P = 2.5 × 10 -15 ; independent to the primary association), reduced FCN2 levels (β = -0.22,P = 2.6 × 10 -32 ), higher FCN1 levels (β = 0.17, P = 1.4 × 10 -17 ) and lower C1QTNF9 levels (β = -0”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 23

  1. 10.1056/NEJM200104053441406 · DOI
  2. 10.1016/S0952-7915(00)00185-0 · DOI
  3. 10.1038/386506a0 · DOI
  4. Vorup-Jensen T, 2000, J Immunol, 165, 2093, 10.4049/jimmunol.165.4.2093 · DOI
  5. 10.1016/S1074-7613(01)00161-3 · DOI
  6. Stover CM, 1999, J Immunol, 162, 3481, 10.4049/jimmunol.162.6.3481 · DOI
  7. 10.1034/j.1600-065X.2001.1800108.x · DOI
  8. 10.1016/S1567-5769(00)00052-7 · DOI
  9. Johnson U, 1983, Acta Pathol Microbiol Immunol Scand (C), 91, 147
  10. 10.1016/0022-1759(81)90107-1 · DOI
  11. Sjöholm AG, Truedsson L, Jensenius JC. Complement pathways and meningococcal disease: diagnostic aspects. In: Pollard AJ, Maiden MCJ, eds. Meningococcal disease: methods and protocols. Totowa, N.J.: Humana Press, 2001:529-47. · DOI
  12. 10.1111/j.1365-3083.1992.tb02982.x · DOI
  13. 10.1016/S0022-1759(01)00453-7 · DOI
  14. Thiel S, 2000, J Immunol, 165, 878, 10.4049/jimmunol.165.2.878 · DOI
  15. 10.1078/0171-2985-00145 · DOI
  16. 10.1016/S0022-1759(00)00198-8 · DOI
  17. 10.1006/jmbi.1997.1423 · DOI
  18. Thielens NM, 2001, J Immunol, 166, 5068, 10.4049/jimmunol.166.8.5068 · DOI
  19. 10.1074/jbc.M103539200 · DOI
  20. Figueroa JE, 1991, Clin Microbiol Rev, 4, 359, 10.1128/CMR.4.3.359 · DOI
  21. 10.1016/S0140-6736(02)08516-1 · DOI
  22. 10.1097/00005792-199501000-00003 · DOI
  23. Sjoholm AG, 1997, J Rheumatol, 24, 871

Cited by

Sorted by citations

Metadata

Authors
Stengaard-Pedersen, K., Thiel, S., Gadjeva, M., Møller-Kristensen, M., Sørensen, R., Jensen, L. T., Sjöholm, A. G., Fugger, L., & Jensenius, J. C.
Affiliations
  • Aarhus University (DK)
  • Aarhus University Hospital (DK)
  • Lund University (SE)
Venue
New England Journal of Medicine
Published
2003-08-07
Volume
349
Issue
6
Pages
554-560
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2085921825
Cited by
253
References
1
Citations by year
2026: 3 · 2025: 6 · 2024: 5 · 2023: 4 · 2022: 9 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 11 · 2017: 6 · 2016: 12 · 2015: 13 · 2014: 12 · 2013: 20 · 2012: 11
FWCI
4.85
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Keywords
mannose-binding lectin, complement activation, pneumococcal pneumonia, ulcerative colitis, systemic lupus erythematosus, serine protease
MeSH terms
Adult, Antibodies, Monoclonal, Colitis, Ulcerative, Complement System Proteins, Humans, Male, Pulmonary Fibrosis, Serine Endopeptidases, Molecular Structure, Point Mutation, Sequence Analysis, DNA, Complement Pathway, Mannose-Binding Lectin, Mannose-Binding Protein-Associated Serine Proteases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review